Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03671590
Brief Title: Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies

First Submitted : September 12, 2018
First Submitted that Met QC Criteria : September 12, 2018
First Posted : September 14, 2018

Last Update Submitted that Met QC Criteria : April 7, 2021
Last Update Posted : April 8, 2021